BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 24456503)

  • 41. [Sacrococcygeal chordoma. Results of radical operation].
    Rosell Pradas J; Ruiz Morales M; Guerrero Fernández JA; Vara-Thorbeck R
    Zentralbl Chir; 1991; 116(21):1253-7. PubMed ID: 1796661
    [No Abstract]   [Full Text] [Related]  

  • 42. Chordoma of the mobile spine and sacrum: a retrospective analysis of a series of patients surgically treated at two referral centers.
    Stacchiotti S; Casali PG; Lo Vullo S; Mariani L; Palassini E; Mercuri M; Alberghini M; Pilotti S; Zanella L; Gronchi A; Picci P
    Ann Surg Oncol; 2010 Jan; 17(1):211-9. PubMed ID: 19847568
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Chordoma of the cranial base: the McGill experience.
    Mizerny BR; Kost KM
    J Otolaryngol; 1995 Feb; 24(1):14-9. PubMed ID: 7769640
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Phase II trial of bevacizumab and erlotinib in carcinomas of unknown primary site: the Minnie Pearl Cancer Research Network.
    Hainsworth JD; Spigel DR; Farley C; Thompson DS; Shipley DL; Greco FA;
    J Clin Oncol; 2007 May; 25(13):1747-52. PubMed ID: 17470864
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Cediranib with mFOLFOX6 versus bevacizumab with mFOLFOX6 as first-line treatment for patients with advanced colorectal cancer: a double-blind, randomized phase III study (HORIZON III).
    Schmoll HJ; Cunningham D; Sobrero A; Karapetis CS; Rougier P; Koski SL; Kocakova I; Bondarenko I; Bodoky G; Mainwaring P; Salazar R; Barker P; Mookerjee B; Robertson J; Van Cutsem E
    J Clin Oncol; 2012 Oct; 30(29):3588-95. PubMed ID: 22965961
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Chordoma: experience with thirteen cases.
    POPPEN JL; KING AB
    J Neurosurg; 1952 Mar; 9(2):139-63. PubMed ID: 14908650
    [No Abstract]   [Full Text] [Related]  

  • 47. [Two cases of chordoma of the base of the skull].
    Baliazin VA; Gelenka AM; Chilikin LA
    Vopr Neirokhir; 1975; (3):55-8. PubMed ID: 1199006
    [No Abstract]   [Full Text] [Related]  

  • 48. [Sacral chordoma: retrospective review of 11 surgically treated cases].
    Jeanrot C; Vinh TS; Anract P; De Pinieux G; Ouaknine M; Forest M; Tomeno B
    Rev Chir Orthop Reparatrice Appar Mot; 2000 Nov; 86(7):684-93. PubMed ID: 11104990
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Chordoma.
    Hueng DY; Ma HI; Sytwu HK
    J Neurosurg Spine; 2013 May; 18(5):533-4. PubMed ID: 23414004
    [No Abstract]   [Full Text] [Related]  

  • 50. VeriStrat® has a prognostic value for patients with advanced non-small cell lung cancer treated with erlotinib and bevacizumab in the first line: pooled analysis of SAKK19/05 and NTR528.
    Gautschi O; Dingemans AM; Crowe S; Peters S; Roder H; Grigorieva J; Roder J; Zappa F; Pless M; Brutsche M; Baty F; Bubendorf L; Hsu Schmitz SF; Na KJ; Carbone D; Stahel R; Smit E
    Lung Cancer; 2013 Jan; 79(1):59-64. PubMed ID: 23122759
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Transoral extirpation of cliosl chordoma].
    Holub M; Fusek I
    Cesk Otolaryngol; 1974 Aug; 23(4):252-5. PubMed ID: 4422575
    [No Abstract]   [Full Text] [Related]  

  • 52. Response. Chordoma.
    Bayrak OF; Gulluoglu S; Aydemir E
    J Neurosurg Spine; 2013 May; 18(5):534. PubMed ID: 23776939
    [No Abstract]   [Full Text] [Related]  

  • 53. Combination of paclitaxel and bevacizumab in heavily pre-treated non-small-cell lung cancer (NSCLC) patients: a case series study on 15 patients.
    Le Moulec S; Hadoux J; Gontier E; Chargari C; Helissey C; Lamand V; Tanz R; Farace F; Vedrine L; Bonardel G; Soria JC; Besse B
    Bull Cancer; 2013 Dec; 100(12):30-7. PubMed ID: 24316967
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Surgical treatment of sacro-coccygeal chordoma].
    Varga PP
    Ideggyogy Sz; 2003 Jan; 56(1-2):20-7. PubMed ID: 12690786
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Morphological characteristics, especially the malignant features, of chordoma in comparison with the notochord].
    Miyauchi M; Maruyama K
    Gan No Rinsho; 1988 Aug; 34(9):1089-95. PubMed ID: 3172514
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Is there a role for immune checkpoint inhibitors in chordoma?
    Assi T
    Immunotherapy; 2021 Aug; 13(12):967-970. PubMed ID: 34078088
    [No Abstract]   [Full Text] [Related]  

  • 57. [Chordomata].
    BISSI A; ROSENHOLZ U
    Tumori; 1952; 20(Suppl.):1-71. PubMed ID: 13196167
    [No Abstract]   [Full Text] [Related]  

  • 58. Commentary: Computational Drug Repositioning Identifies Potentially Active Therapies for Chordoma.
    Eichberg DG; Komotar RJ; Ivan ME
    Neurosurgery; 2021 Jan; 88(2):E203-E204. PubMed ID: 33009573
    [No Abstract]   [Full Text] [Related]  

  • 59. Chordoma Genetic Aberrations and Targeted Therapies Panorama: A Systematic Literature Review.
    Agosti E; Antonietti S; Zeppieri M; Ius T; Fiorindi A; Tel A; Robiony M; Panciani PP; Fontanella MM
    J Clin Med; 2024 May; 13(9):. PubMed ID: 38731241
    [No Abstract]   [Full Text] [Related]  

  • 60. Activity of pemetrexed in pre-clinical chordoma models and humans.
    Kesari S; Wang F; Juarez T; Ashili S; Patro CPK; Carrillo J; Nguyen M; Truong J; Levy J; Sommer J; Freed DM; Xiu J; Takasumi Y; Bouffet E; Gill JM
    Sci Rep; 2023 May; 13(1):7317. PubMed ID: 37147496
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.